31-07-2024 |
PM |
|
SYRS |
Syros Pharmaceuticals, Inc. |
172.93 |
-0.70 |
-0.79 |
-1.30 |
Syros Pharmaceuticals GAAP EPS of -$0.59 beats by $0.18 [7/31/2024 7:32 AM] |
6.00 |
-0.26 (-4.15%) |
0.0 |
0.0 (0.00%) |
2.09 - 8.17 |
116,355 |
70,000 |
0 |
|
|
14-05-2024 |
PM |
|
SYRS |
Syros Pharmaceuticals, Inc. |
131.48 |
-0.79 |
-0.89 |
-0.85 |
Syros Pharmaceuticals GAAP EPS of -$0.10 beats by $0.77 [5/14/2024 7:31 AM] |
5.43 |
0.38 (7.41%) |
5.20 |
0.14 (2.77%) |
2.09 - 8.17 |
154,034 |
120,000 |
1,206 |
|
|
27-03-2024 |
PM |
|
SYRS |
Syros Pharmaceuticals, Inc. |
134.83 |
-1.19 |
-1.23 |
-1.28 |
Syros Pharmaceuticals GAAP EPS of -$2.18 misses by $1.04, revenue of $0.4M misses by $1.6M [3/27/2024 7:32 AM] |
5.88 |
-0.37 (-5.92%) |
5.59 |
-0.66 (-10.57%) |
2.09 - 8.17 |
409,206 |
130,000 |
4,074 |
|
|
14-11-2023 |
PM |
|
SYRS |
Syros Pharmaceuticals, Inc. |
57.99 |
-1.35 |
-1.12 |
-2.41 |
Syros Pharmaceuticals GAAP EPS of -$1.43 misses by $0.29, revenue of $3.76M misses by $0.18M [11/14/2023 7:32 AM] |
2.72 |
0.03 (1.12%) |
0.0 |
0.0 (0.00%) |
2.09 - 5.67 |
42,823 |
70,000 |
0 |
|
|
08-08-2023 |
PM |
|
SYRS |
Syros Pharmaceuticals, Inc. |
75.17 |
-1.30 |
-1.11 |
-5.40 |
Syros Pharmaceuticals GAAP EPS of $1.30 beats by $2.43, revenue of $2.8M misses by $0.7M [8/8/2023 7:37 AM] |
3.66 |
-0.02 (-0.54%) |
3.60 |
-0.08 (-2.17%) |
2.42 - 10.50 |
40,168 |
70,000 |
1,008 |
|
|
10-05-2023 |
PM |
7:30 AM ET (May 10) |
SYRS |
Syros Pharmaceuticals, Inc. |
61.84 |
-0.85 |
-1.12 |
4.00 |
Syros Pharmaceuticals GAAP EPS of -$0.85 beats by $0.20, revenue of $3M misses by $0.3M [5/10/2023 7:32 AM] |
3.44 |
0.33 (10.61%) |
0.0 |
0.0 (0.00%) |
2.42 - 11.50 |
220,912 |
70,000 |
0 |
|
|
02-03-2023 |
PM |
7:30 AM ET (Mar 2) |
SYRS |
Syros Pharmaceuticals, Inc. |
79.89 |
-1.28 |
-1.27 |
-4.20 |
Syros Pharmaceuticals GAAP EPS of -$0.17 beats by $1.13 [3/2/2023 7:34 AM] |
3.72 |
0.06 (1.64%) |
3.79 |
0.13 (3.55%) |
3.02 - 14.30 |
110,684 |
90,000 |
2,581 |
|
|
14-11-2022 |
PM |
7:30 AM ET (Nov 14) |
SYRS |
Syros Pharmaceuticals, Inc. |
76.09 |
-2.41 |
-3.91 |
-4.10 |
Syros Pharmaceuticals GAAP EPS of -$3.21 beats by $0.30, revenue of $3.9M misses by $1.28M [11/14/2022 7:35 AM] |
3.72 |
-0.26 (-6.53%) |
4.00 |
0.02 (0.50%) |
3.52 - 43.40 |
143,351 |
120,000 |
1,234 |
|
|
09-08-2022 |
PM |
7:30 AM ET (Aug 9) |
SYRS |
Syros Pharmaceuticals, Inc. |
60.06 |
-0.54 |
-0.42 |
-0.36 |
Syros Pharmaceuticals GAAP EPS of -$0.54 misses by $0.13, revenue of $6.28M beats by $1.5M [8/9/2022 7:33 AM] |
0.9201 |
-0.06 (-5.64%) |
0.87 |
-0.10 (-10.77%) |
0.65 - 5.64 |
919,867 |
1,400,000 |
106,980 |
|
|
16-05-2022 |
PM |
7:30 AM ET (May 16) |
SYRS |
Syros Pharmaceuticals, Inc. |
52.83 |
-0.40 |
-0.48 |
-0.23 |
Syros Pharmaceuticals GAAP EPS of -$0.40 beats by $0.07, revenue of $5.47M beats by $0.55M [5/16/2022 7:31 AM] |
0.77 |
-0.13 (-14.34%) |
0.93 |
0.03 (3.46%) |
0.76 - 7.03 |
1,016,141 |
810,000 |
2,693 |
|
|
15-03-2022 |
PM |
7:30 AM ET (Mar 15) |
SYRS |
Syros Pharmaceuticals |
76.00 |
-0.42 |
-0.44 |
0.00 |
Syros Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08, revenue of $78M beats by $73.16M [3/15/2022 7:37 AM] |
1.36 |
0.07 (5.79%) |
1.16 |
0.09 (8.41%) |
1.12 - 9.80 |
392,240 |
437,743 |
4,523 |
|
|
05-11-2021 |
PM |
7:30 AM ET (Nov 5) |
SYRS |
Syros Pharmaceuticals, Inc. |
271.88 |
-0.41 |
-0.43 |
-0.43 |
Syros Pharmaceuticals EPS beats by $0.03, beats on revenue [11/5/2021 7:40 AM] |
4.57 |
0.15 (3.39%) |
4.50 |
0.08 (1.81%) |
4.00 - 15.65 |
480,245 |
310,000 |
1,529 |
|
|
05-08-2021 |
PM |
7:30 AM ET (Aug 5) |
SYRS |
Syros Pharmaceuticals, Inc. |
283.31 |
-0.36 |
-0.36 |
-0.38 |
Syros Pharmaceuticals EPS beats by $0.03, beats on revenue [8/5/2021 7:47 AM] |
4.89 |
0.38 (8.43%) |
4.70 |
0.19 (4.21%) |
4.35 - 15.65 |
958,145 |
480,000 |
420,253 |
|
|
06-05-2021 |
PM |
7:30 AM ET (May 6) |
SYRS |
Syros Pharmaceuticals, Inc. |
348.21 |
-0.23 |
-0.55 |
-0.39 |
Syros Pharmaceuticals EPS beats by $0.24, beats on revenue [5/6/2021 7:33 AM] |
5.53 |
0.05 (0.91%) |
5.53 |
0.0 (0.00%) |
5.07 - 15.65 |
789,932 |
550,000 |
6,364 |
|
|
04-03-2021 |
PM |
7:30 AM ET (Mar 4) |
SYRS |
Syros Pharmaceuticals, Inc. |
564.23 |
-0.61 |
-0.54 |
-0.46 |
Syros Pharmaceuticals EPS misses by $0.12, beats on revenue [3/4/2021 7:39 AM] |
7.99 |
-0.33 (-3.97%) |
8.26 |
-0.06 (-0.72%) |
4.26 - 15.65 |
951,160 |
754,073 |
1,957 |
|
|
05-11-2020 |
AH |
4:05 PM ET (Nov 5) |
SYRS |
Syros Pharmaceuticals, Inc. |
346.88 |
-0.43 |
-0.38 |
-0.47 |
Syros Pharmaceuticals EPS misses by $0.05, beats on revenue [11/5/2020 5:49 PM] |
8.45 |
0.34 (4.19%) |
8.15 |
0.04 (0.49%) |
4.26 - 14.69 |
307,218 |
634,624 |
700 |
|
|
06-08-2020 |
PM |
7:30 AM ET (Aug 6) |
SYRS |
Syros Pharmaceuticals, Inc. |
473.84 |
-0.38 |
-0.40 |
-0.47 |
Syros Pharmaceuticals EPS beats by $0.02, beats on revenue [8/6/2020 7:41 AM] |
11.81 |
0.53 (4.70%) |
11.28 |
0.0 (0.00%) |
4.26 - 12.75 |
141,785 |
179,012 |
5,011 |
|
|